Prestige Consumer Healthcare PBH Gain/Loss on Asset Sales
Gain/Loss on Asset Sales at other companies
Other financials
Where this comes from
Reported directly by Prestige Consumer Healthcare in its filing.
Tagged under the XBRL concept us-gaap:GainLossOnSaleOfPropertyPlantEquipment.
The official record: Prestige Consumer Healthcare’s 10-K, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Prestige Consumer Healthcare's gain/loss on asset sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Prestige Consumer Healthcare's gain/loss on asset sales?
- Prestige Consumer Healthcare (PBH) reported gain/loss on asset sales of -$25K in Q1 2026.
- How has Prestige Consumer Healthcare's gain/loss on asset sales changed year-over-year?
- Prestige Consumer Healthcare's gain/loss on asset sales increased by 83.4% year-over-year, from -$151K to -$25K.
- What is the long-term trend for Prestige Consumer Healthcare's gain/loss on asset sales?
- Over 4 years (2022 to 2026), Prestige Consumer Healthcare's gain/loss on asset sales has grown at a -11.7% compound annual growth rate (CAGR), from -$271K to -$165K.
- What does gain/loss on asset sales mean?
- Gains or losses on asset disposals removed from operating cash flow — the cash impact is captured in investing activities.